CNSIG Inner Mongolia Chemical Industry (600328.SH) subsidiary's safety production permit has expired and production has been suspended.

15:43 31/03/2026

China Salt Chemical (600328.SH) announced that its wholly-owned subsidiary, Zhongyan Kunshan Co., Ltd. (referred to as "Zhongyan Kunshan"), has received a "Decision on On-Site Handling Measures" from the Kunshan Emergency Management Bureau. According to the annual plan, starting from March 22, 2026, Zhongyan Kunshan's production unit will undergo annual shutdown and maintenance. On March 27, 2026, Zhongyan Kunshan received a "Decision on On-Site Handling Measures" from the Kunshan Emergency Management Bureau due to the expiration of its "Safety Production License," notifying it to temporarily suspend production starting from March 27, 2026.

CNSIG Inner Mongolia Chemical Industry (600328.SH) announced that its wholly-owned subsidiary Kunshan China National Salt Industry Group Co., Ltd. (referred to as "Kunshan China National Salt Industry Group") received a "Decision on Site Handling Measures" from the Kunshan Emergency Management Bureau. According to the annual plan, Kunshan China National Salt Industry Group's production facilities will undergo annual shutdown and maintenance starting from March 22, 2026. On March 27, 2026, as its "Safety Production License" expired, Kunshan China National Salt Industry Group received a "Decision on Site Handling Measures" from the Kunshan Emergency Management Bureau, notifying them to temporarily suspend production starting from March 27, 2026.

CONCH MAT TECH (02560) announced its annual performance, with a net profit attributable to shareholders of 109 million yuan, a decrease of 12.95% year-on-year.

MGM CHINA (02282) Cancels 39,200 Repurchased Shares.

SUNSHINE PHARMA (06887) announced its performance for 2025, with a net profit attributable to equity shareholders of approximately 272 million yuan, turning a loss into a profit year-on-year.

CONCH MAT TECH (02560) announced its annual performance, with a net profit attributable to shareholders of 109 million yuan, a decrease of 12.95% year-on-year.

MGM CHINA (02282) Cancels 39,200 Repurchased Shares.

SUNSHINE PHARMA (06887) announced its performance for 2025, with a net profit attributable to equity shareholders of approximately 272 million yuan, turning a loss into a profit year-on-year.